Market closedNon-fractional
Accolade/ACCD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Accolade
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
Ticker
ACCD
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Providers and Services
Headquarters
Seattle, United States
Employees
2,400
Website
www.accolade.com
Accolade Metrics
BasicAdvanced
$308M
Market cap
-
P/E ratio
-$1.17
EPS
2.00
Beta
-
Dividend rate
Price and volume
Market cap
$308M
Beta
2
Financial strength
Current ratio
2.796
Quick ratio
2.624
Long term debt to equity
53.623
Total debt to equity
55.276
Interest coverage (TTM)
-36.19%
Management effectiveness
Return on assets (TTM)
-7.89%
Return on equity (TTM)
-20.01%
Valuation
Price to revenue (TTM)
0.679
Price to book
0.7
Price to tangible book (TTM)
551.95
Price to free cash flow (TTM)
-19.463
Growth
Revenue change (TTM)
16.37%
Earnings per share change (TTM)
-45.69%
3-year revenue growth (CAGR)
30.54%
3-year earnings per share growth (CAGR)
-16.82%
What the Analysts think about Accolade
Analyst Ratings
Majority rating from 17 analysts.
Accolade Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$125M
25.68%
Net income
-$7.5M
-64.29%
Profit margin
-6.00%
-71.62%
Accolade Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
-$0.52
-$0.43
-$0.28
-$0.10
-
Expected
-$0.62
-$0.54
-$0.44
-$0.07
-$0.48
Surprise
-16.12%
-19.84%
-36.67%
41.30%
-
Accolade News
AllArticlesVideos
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD)
Accesswire·9 hours ago
The Schall Law Firm Encourages Accolade Inc Investors To Join The Alleged Securities Fraud Probe
Accesswire·9 hours ago
Accolade, Inc. (ACCD) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
Accesswire·9 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Accolade stock?
Accolade (ACCD) has a market cap of $308M as of July 27, 2024.
What is the P/E ratio for Accolade stock?
The price to earnings (P/E) ratio for Accolade (ACCD) stock is 0 as of July 27, 2024.
Does Accolade stock pay dividends?
No, Accolade (ACCD) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Accolade dividend payment date?
Accolade (ACCD) stock does not pay dividends to its shareholders.
What is the beta indicator for Accolade?
Accolade (ACCD) has a beta rating of 2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Accolade stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.